Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 1
2019 1
2020 2
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort.
Gontika M, Skarlis C, Artemiadis A, Pons R, Mastroyianni S, Vartzelis G, Theodorou V, Kilindireas K, Stefanis L, Dalakas M, Chrousos G, Anagnostouli M. Gontika M, et al. Mult Scler J Exp Transl Clin. 2020 Feb 24;6(1):2055217320908046. doi: 10.1177/2055217320908046. eCollection 2020 Jan-Mar. Mult Scler J Exp Transl Clin. 2020. PMID: 32133149 Free PMC article.
Moderately and Late Preterm Infants: Short- and Long-Term Outcomes From a Registry-Based Cohort.
Smyrni N, Koutsaki M, Petra M, Nikaina E, Gontika M, Strataki H, Davora F, Bouza H, Damianos G, Skouteli H, Mastroyianni S, Dalivigka Z, Dinopoulos A, Tzaki M, Papavasiliou A. Smyrni N, et al. Among authors: gontika m. Front Neurol. 2021 Feb 12;12:628066. doi: 10.3389/fneur.2021.628066. eCollection 2021. Front Neurol. 2021. PMID: 33643206 Free PMC article.
Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions-a single-center retrospective observational study.
Gontika M, Skarlis C, Markoglou N, Tzanetakos D, Vakrakou A, Toulas P, Koutsis G, Evangelopoulos ME, Pons R, Dardiotis E, Chrousos G, Dalakas M, Stefanis L, Anagnostouli M. Gontika M, et al. Naunyn Schmiedebergs Arch Pharmacol. 2022 Aug;395(8):933-943. doi: 10.1007/s00210-022-02238-y. Epub 2022 Apr 26. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35471586
First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center.
Skarlis C, Markoglou N, Gontika M, Bougea A, Katsavos S, Artemiadis A, Chrousos G, Dalakas M, Stefanis L, Anagnostouli M. Skarlis C, et al. Among authors: gontika m. Neurol Sci. 2023 Feb;44(2):693-701. doi: 10.1007/s10072-022-06431-y. Epub 2022 Oct 5. Neurol Sci. 2023. PMID: 36197577 Free PMC article.
11 results